Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials

Realization of the immense potential of nanomaterials for biomedical applications will require a thorough understanding of how they interact with cells, tissues, and organs. There is evidence that, depending on their physicochemical properties and subsequent interactions, nanomaterials are indeed taken up by cells. However, the subsequent release and/or intracellular degradation of the materials, transfer to other cells, and/or translocation across tissue barriers are still poorly understood. The involvement of these cellular clearance mechanisms strongly influences the long‐term fate of used nanomaterials, especially if one also considers repeated exposure. Several nanomaterials, such as liposomes and iron oxide, gold, or silica nanoparticles, are already approved by the American Food and Drug Administration for clinical trials; however, there is still a huge gap of knowledge concerning their fate in the body. Herein, clinically relevant nanomaterials, their possible modes of exposure, as well as the biological barriers they must overcome to be effective are reviewed. Furthermore, the biodistribution and kinetics of nanomaterials and their modes of clearance are discussed, knowledge of the long‐term fates of a selection of nanomaterials is summarized, and the critical points that must be considered for future research are addressed.

[1]  J. S. Lobo,et al.  Development and characterization of mucoadhesive buccal gels containing lipid nanoparticles of ibuprofen. , 2017, International journal of pharmaceutics.

[2]  M. Cotte,et al.  Synchrotron-based ν-XRF mapping and μ-FTIR microscopy enable to look into the fate and effects of tattoo pigments in human skin , 2017, Scientific Reports.

[3]  Jiye Shi,et al.  Real-time visualization of clustering and intracellular transport of gold nanoparticles by correlative imaging , 2017, Nature Communications.

[4]  R. J. Alves,et al.  Synthesis, characterization and radiolabeling of polymeric nano-micelles as a platform for tumor delivering. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  D. Vanhecke,et al.  Quantifying nanoparticle cellular uptake: which method is best? , 2017, Nanomedicine.

[6]  Paul Keselman,et al.  Tracking short-term biodistribution and long-term clearance of SPIO tracers in magnetic particle imaging , 2017, Physics in medicine and biology.

[7]  Manuela Semmler-Behnke,et al.  Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1 , 2017, Nanotoxicology.

[8]  Manuela Semmler-Behnke,et al.  Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3 , 2017, Nanotoxicology.

[9]  Manuela Semmler-Behnke,et al.  Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2 , 2017, Nanotoxicology.

[10]  J. Hubbuch,et al.  Effect of PEG molecular weight and PEGylation degree on the physical stability of PEGylated lysozyme. , 2017, International journal of pharmaceutics.

[11]  N. Khashab,et al.  Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles , 2017, Advanced materials.

[12]  Mandip Singh,et al.  Novel amphiphilic lipid augments the co‐delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Wei Wu,et al.  Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles. , 2017, Nanoscale.

[14]  Ian D. McGilvray,et al.  Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Jie Chen,et al.  Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy , 2016, International journal of nanomedicine.

[16]  J. Duan,et al.  Mitochondria-targeted drug delivery system for cancer treatment , 2016, Journal of drug targeting.

[17]  Elizabeth I. Maurer,et al.  Intracellular accumulation and dissolution of silver nanoparticles in L-929 fibroblast cells using live cell time-lapse microscopy , 2016, Nanotoxicology.

[18]  K. Adibkia,et al.  Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery , 2016, Archives of pharmacal research.

[19]  Sanghoon Ko,et al.  Preparation and Characterization of Mucoadhesive Buccal Nanoparticles Using Chitosan and Dextran Sulfate. , 2016, Journal of agricultural and food chemistry.

[20]  K. Thurecht,et al.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date , 2016, Pharmaceutical Research.

[21]  A. Arnaout,et al.  Carbon Nanotubes in Biomedical Applications: Factors, Mechanisms, and Remedies of Toxicity. , 2016, Journal of medicinal chemistry.

[22]  P. Dutta,et al.  Critical assessment of toxicological effects of ingested nanoparticles , 2016 .

[23]  N. Willenbacher,et al.  Size-Limited Penetration of Nanoparticles into Porcine Respiratory Mucus after Aerosol Deposition. , 2016, Biomacromolecules.

[24]  Y. Gupta,et al.  Biokinetics of ultrafine gold nanoparticles (AuNPs) relating to redistribution and urinary excretion: a long-term in vivo study , 2016, Journal of drug targeting.

[25]  Olivier Jolliet,et al.  Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles , 2016, International journal of nanomedicine.

[26]  Barbara Ruozi,et al.  Nanoparticle transport across the blood brain barrier , 2016, Tissue barriers.

[27]  Susan Hua,et al.  Advances and Challenges of Liposome Assisted Drug Delivery , 2015, Front. Pharmacol..

[28]  Andrzej S Pitek,et al.  Virus-Based Nanoparticles as Versatile Nanomachines. , 2015, Annual review of virology.

[29]  Linlin Li,et al.  Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[30]  F. Kiessling,et al.  Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects. , 2015, Chemical reviews.

[31]  A. Tsourkas,et al.  Biodistribution, Clearance, and Toxicology of Polymeric Micelles Loaded with 0.9 or 5 nm Gold Nanoparticles. , 2015, Journal of biomedical nanotechnology.

[32]  Ru-jing Ren,et al.  The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration , 2015, Translational Neurodegeneration.

[33]  Manfred F. Maitz,et al.  Applications of synthetic polymers in clinical medicine , 2015 .

[34]  Sandor Balog,et al.  Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. , 2015, Chemical Society reviews.

[35]  J. Cheon,et al.  Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy. , 2015, Chemical reviews.

[36]  Xiue Jiang,et al.  Monitoring of the Enzymatic Degradation of Protein Corona and Evaluating the Accompanying Cytotoxicity of Nanoparticles. , 2015, ACS applied materials & interfaces.

[37]  Jianbin Tang,et al.  The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment. , 2015, ACS nano.

[38]  Jie Zheng,et al.  Clearance Pathways and Tumor Targeting of Imaging Nanoparticles. , 2015, ACS nano.

[39]  Steffen Loft,et al.  Nanomaterial translocation–the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs–a review , 2015, Critical reviews in toxicology.

[40]  Raimo Hartmann,et al.  In vivo integrity of polymer-coated gold nanoparticles. , 2015, Nature nanotechnology.

[41]  S. Gordon,et al.  From the Reticuloendothelial to Mononuclear Phagocyte System – The Unaccounted Years , 2015, Front. Immunol..

[42]  Natalie von Goetz,et al.  Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments , 2015, Particle and Fibre Toxicology.

[43]  M. Eblan,et al.  Clinical Translation of Nanomedicine. , 2015, Chemical reviews.

[44]  T Lammers,et al.  Applications of nanoparticles for diagnosis and therapy of cancer. , 2015, The British journal of radiology.

[45]  Bruno F B Silva,et al.  Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: A platform for investigating early endosomal events. , 2015, Biochimica et biophysica acta.

[46]  H. Bouwmeester,et al.  Translocation of differently sized and charged polystyrene nanoparticles in in vitro intestinal cell models of increasing complexity , 2015, Nanotoxicology.

[47]  Yuqing Su,et al.  Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs , 2015, International journal of nanomedicine.

[48]  Mary Gulumian,et al.  Dissolution and biodurability: Important parameters needed for risk assessment of nanomaterials , 2015, Particle and Fibre Toxicology.

[49]  Tingting Jin,et al.  The effects of size and surface modification of amorphous silica particles on biodistribution and liver metabolism in mice , 2015, Nanotechnology.

[50]  M. A. Wouters,et al.  Potential role of glutathione in evolution of thiol-based redox signaling sites in proteins , 2015, Front. Pharmacol..

[51]  Olivier Tillement,et al.  Long-term in vivo clearance of gadolinium-based AGuIX nanoparticles and their biocompatibility after systemic injection. , 2015, ACS nano.

[52]  Chunying Chen,et al.  Fast intracellular dissolution and persistent cellular uptake of silver nanoparticles in CHO-K1 cells: implication for cytotoxicity , 2015, Nanotoxicology.

[53]  H. Maeda,et al.  Synthesis and therapeutic effect of styrene–maleic acid copolymer-conjugated pirarubicin , 2015, Cancer science.

[54]  Yuan Yang,et al.  Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer. , 2015, Molecular pharmaceutics.

[55]  Matias Ostrowski,et al.  Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions , 2014, Front. Immunol..

[56]  Mi-Kyung Kim,et al.  Tissue distribution and excretion kinetics of orally administered silica nanoparticles in rats , 2014, International journal of nanomedicine.

[57]  Tiago Morais,et al.  Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[58]  Mithat Gönen,et al.  Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe , 2014, Science Translational Medicine.

[59]  M. Ferrari,et al.  Degradation and biocompatibility of multistage nanovectors in physiological systems. , 2014, Journal of biomedical materials research. Part A.

[60]  Omid C Farokhzad,et al.  Insight into nanoparticle cellular uptake and intracellular targeting. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[61]  Benjamin Michen,et al.  Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages , 2014, Beilstein journal of nanotechnology.

[62]  M. Falzarano,et al.  Biodistribution studies of polymeric nanoparticles for drug delivery in mice. , 2014, Human gene therapy.

[63]  R. Babu,et al.  Nanomedicine Scale-up Technologies: Feasibilities and Challenges , 2014, AAPS PharmSciTech.

[64]  Florent Ginhoux,et al.  Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny , 2014, Nature Reviews Immunology.

[65]  V. Allan,et al.  The role of the cytoskeleton and molecular motors in endosomal dynamics , 2014, Seminars in cell & developmental biology.

[66]  Jayoung Jeong,et al.  Quantitative Determination of Silica Nanoparticles in Biological Matrices and Their Pharmacokinetics and Toxicokinetics in Rats , 2014 .

[67]  Anette Müllertz,et al.  In vitro models for the prediction of in vivo performance of oral dosage forms. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[68]  O. Tillement,et al.  Targeting and in vivo imaging of non-small–cell lung cancer using nebulized multimodal contrast agents , 2014, Proceedings of the National Academy of Sciences.

[69]  F. Stellacci,et al.  A general mechanism for intracellular toxicity of metal-containing nanoparticles† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c4nr01234h Click here for additional data file. , 2014, Nanoscale.

[70]  Ji-Ho Park,et al.  Endocytosis and exocytosis of nanoparticles in mammalian cells , 2014, International journal of nanomedicine.

[71]  P. Wick,et al.  Inhalation Pathway as a Promising Portal of Entry: What Has to Be Considered in Designing New Nanomaterials for Biomedical Application? , 2014 .

[72]  J. Kerry,et al.  Evaluation and simulation of silver and copper nanoparticle migration from polyethylene nanocomposites to food and an associated exposure assessment. , 2014, Journal of agricultural and food chemistry.

[73]  Manuela Semmler-Behnke,et al.  Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. , 2014, ACS nano.

[74]  K. Macleod,et al.  Mitochondrial Dysfunction in Cancer , 2013, Front. Oncol..

[75]  Morteza Mahmoudi,et al.  Exocytosis of nanoparticles from cells: role in cellular retention and toxicity. , 2013, Advances in colloid and interface science.

[76]  R. Ransohoff,et al.  Development, maintenance and disruption of the blood-brain barrier , 2013, Nature Medicine.

[77]  T. Ishida,et al.  The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[78]  M. Ferrari,et al.  Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics. , 2013, Biomaterials.

[79]  Fengjuan Wang,et al.  The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[80]  M. Bañobre‐López,et al.  Magnetic nanoparticle-based hyperthermia for cancer treatment. , 2013, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

[81]  Rihe Liu,et al.  The smart targeting of nanoparticles. , 2013, Current pharmaceutical design.

[82]  Xueya Wang,et al.  Intelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical application. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[83]  Z. Gu,et al.  Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking , 2013, Theranostics.

[84]  Elizabeth I. Maurer,et al.  Systematic analysis of silver nanoparticle ionic dissolution by tangential flow filtration: toxicological implications , 2013, Nanotoxicology.

[85]  P. Saftig,et al.  Lysosomal Membrane Proteins and Their Central Role in Physiology , 2013, Traffic.

[86]  Kinam Park,et al.  Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. , 2013, Advanced drug delivery reviews.

[87]  P. Perriat,et al.  The biodistribution of gold nanoparticles designed for renal clearance. , 2013, Nanoscale.

[88]  Ki Young Choi,et al.  Effect of injection routes on the biodistribution, clearance, and tumor uptake of carbon dots. , 2013, ACS nano.

[89]  Bengt Fadeel,et al.  Interactions of engineered nanoparticles with organs protected by internal biological barriers. , 2013, Small.

[90]  N. Zhang,et al.  Polysaccharide-Based Micelles for Drug Delivery , 2013, Pharmaceutics.

[91]  L. Lartigue,et al.  Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring. , 2013, ACS nano.

[92]  Chuan Yang,et al.  The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles. , 2013, Biomaterials.

[93]  Warren C W Chan,et al.  Are quantum dots toxic? Exploring the discrepancy between cell culture and animal studies. , 2013, Accounts of chemical research.

[94]  Courtney R. Thomas,et al.  Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition. , 2013, Small.

[95]  Linlin Li,et al.  The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. , 2013, Biomaterials.

[96]  Dennis E Discher,et al.  Minimal " Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles References and Notes , 2022 .

[97]  W. Kreyling,et al.  Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D. , 2013, Journal of aerosol medicine and pulmonary drug delivery.

[98]  K. Ulbrich,et al.  HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[99]  A. Laties,et al.  Acidic Nanoparticles Are Trafficked to Lysosomes and Restore an Acidic Lysosomal pH and Degradative Function to Compromised ARPE-19 Cells , 2012, PloS one.

[100]  M. Hotopf,et al.  Importance of Thinking Locally for Mental Health: Data from Cross-Sectional Surveys Representing South East London and England , 2012, PloS one.

[101]  K. Dawson,et al.  Biomolecular Coronas Provide the Biological Identity of Nanomaterials , 2017 .

[102]  K. Turteltaub,et al.  Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry. , 2012, Nano letters.

[103]  Kwangmeyung Kim,et al.  Hyaluronic acid-gold nanoparticle/interferon α complex for targeted treatment of hepatitis C virus infection. , 2012, ACS nano.

[104]  Hamidreza Ghandehari,et al.  In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[105]  Claus-Michael Lehr,et al.  Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus , 2012, Proceedings of the National Academy of Sciences.

[106]  D. Hill,et al.  A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia , 2012, Science.

[107]  Stefan Seeger,et al.  Industrial production quantities and uses of ten engineered nanomaterials in Europe and the world , 2012, Journal of Nanoparticle Research.

[108]  Morteza Mahmoudi,et al.  Cell "vision": complementary factor of protein corona in nanotoxicology. , 2012, Nanoscale.

[109]  N. Hondow,et al.  Mechanism of cellular uptake of genotoxic silica nanoparticles , 2012, Particle and Fibre Toxicology.

[110]  Iseult Lynch,et al.  Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[111]  J. Prakash,et al.  Drug targeting to the diseased liver. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[112]  G. Tiram,et al.  Administration, distribution, metabolism and elimination of polymer therapeutics. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[113]  P. Desai,et al.  Overcoming poor oral bioavailability using nanoparticle formulations - opportunities and limitations. , 2012, Drug discovery today. Technologies.

[114]  Lyndon Jones,et al.  Nanomaterials for ocular drug delivery. , 2012, Macromolecular bioscience.

[115]  Wan-Xi Yang,et al.  Nanoparticles and spermatogenesis: how do nanoparticles affect spermatogenesis and penetrate the blood-testis barrier. , 2012, Nanomedicine.

[116]  N. Desai Challenges in Development of Nanoparticle-Based Therapeutics , 2012, The AAPS Journal.

[117]  A. Dudley Tumor endothelial cells. , 2012, Cold Spring Harbor perspectives in medicine.

[118]  Jing Bai,et al.  Cellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistry. , 2012, ACS nano.

[119]  G. Oberdörster,et al.  Nanotoxicology: in Vitro–in Vivo Dosimetry , 2012, Environmental health perspectives.

[120]  D. Sibley,et al.  The Blood-Testis Barrier and Its Implications for Male Contraception , 2012, Pharmacological Reviews.

[121]  Alexander M. Seifalian,et al.  Toxicology and clinical potential of nanoparticles , 2011, Nano today.

[122]  Takeshi Kobayashi,et al.  Cancer hyperthermia using magnetic nanoparticles , 2011, Biotechnology journal.

[123]  S. Schulte,et al.  Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[124]  Ari Helenius,et al.  Endosome maturation , 2011, The EMBO journal.

[125]  H. Gendelman,et al.  Macrophage endocytic trafficking of antiretroviral nanoparticles. , 2011, Nanomedicine.

[126]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[127]  Q. Tao,et al.  Cellular uptake, evolution, and excretion of silica nanoparticles in human cells. , 2011, Nanoscale.

[128]  H. Beitner,et al.  Sunscreen use: controversies, challenges and regulatory aspects , 2011, The British journal of dermatology.

[129]  Juan B. Blanco-Canosa,et al.  Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. , 2011, ACS nano.

[130]  T. Reinheckel,et al.  Specific functions of lysosomal proteases in endocytic and autophagic pathways☆ , 2011, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.

[131]  Dong Chen,et al.  The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.

[132]  Federica Valentini,et al.  Low doses of pristine and oxidized single-wall carbon nanotubes affect mammalian embryonic development. , 2011, ACS nano.

[133]  F. Gendron,et al.  Long term in vivo biotransformation of iron oxide nanoparticles. , 2011, Biomaterials.

[134]  Kit S Lam,et al.  The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. , 2011, Biomaterials.

[135]  Tian Xia,et al.  Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. , 2011, ACS nano.

[136]  Manuela Semmler-Behnke,et al.  Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[137]  Kirsten Sandvig,et al.  Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies , 2011 .

[138]  K. Yadav,et al.  Effect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA Nanoparticles. , 2011, PDA journal of pharmaceutical science and technology.

[139]  Lev Dykman,et al.  Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.

[140]  D. Simberg,et al.  Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems , 2011, Expert opinion on drug delivery.

[141]  Peter Wick,et al.  Nanotoxicology: an interdisciplinary challenge. , 2011, Angewandte Chemie.

[142]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[143]  Xinglu Huang,et al.  Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. , 2011, Biomaterials.

[144]  Yaping Li,et al.  In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.

[145]  Myrtill Simkó,et al.  Risks from accidental exposures to engineered nanoparticles and neurological health effects: A critical review , 2010, Particle and Fibre Toxicology.

[146]  C. Cheng,et al.  Drug transporters, the blood-testis barrier, and spermatogenesis. , 2010, The Journal of endocrinology.

[147]  G. McKerr,et al.  Quantification of nanoparticle uptake by cells using microscopical and analytical techniques. , 2010, Nanomedicine.

[148]  K. Sandvig,et al.  New metal-based nanoparticles for intravenous use: requirements for clinical success with focus on medical imaging. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[149]  R. Jain,et al.  Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.

[150]  Hak Soo Choi,et al.  Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation , 2010, Molecular imaging.

[151]  C. Mou,et al.  Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. , 2010, Angewandte Chemie.

[152]  Kostas Kostarelos,et al.  Physiologically based pharmacokinetic modeling of nanoparticles. , 2010, ACS nano.

[153]  Leon Gradoń,et al.  Nanoparticles in Medicine and Environment: Inhalation and Health Effects , 2010 .

[154]  E. Daviskas,et al.  Mucociliary and cough clearance as a biomarker for therapeutic development. , 2010, Journal of aerosol medicine and pulmonary drug delivery.

[155]  R. Matran,et al.  Characterization of endocytosis and exocytosis of cationic nanoparticles in airway epithelium cells , 2010, Nanotechnology.

[156]  Holger Moch,et al.  Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. , 2010, Toxicology letters.

[157]  U. Schubert,et al.  Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.

[158]  Zongxi Li,et al.  Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. , 2010, Small.

[159]  Y. Alnouti,et al.  Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model. , 2010, Molecular pharmaceutics.

[160]  T. Bein,et al.  Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging. , 2010, Nano letters.

[161]  Chin-Tu Chen,et al.  Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. , 2010, Biomaterials.

[162]  William B. Liechty,et al.  Polymers for drug delivery systems. , 2010, Annual review of chemical and biomolecular engineering.

[163]  Shuming Nie,et al.  Understanding and overcoming major barriers in cancer nanomedicine. , 2010, Nanomedicine.

[164]  A. Narang,et al.  Targeted Delivery of Small and Macromolecular Drugs , 2010 .

[165]  D. Dykxhoorn,et al.  Breaking down the barriers: siRNA delivery and endosome escape , 2010, Journal of Cell Science.

[166]  Catherine J. Murphy,et al.  Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.

[167]  Jinatta Jittiwat,et al.  Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. , 2010, Biomaterials.

[168]  Liyi Shi,et al.  Biodistribution and toxicity of intravenously administered silica nanoparticles in mice , 2010, Archives of Toxicology.

[169]  Indrajit Roy,et al.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. , 2010, ACS nano.

[170]  E. Morselli,et al.  Mitochondrial gateways to cancer. , 2010, Molecular aspects of medicine.

[171]  Ying Liu,et al.  Characterization of gold nanorods in vivo by integrated analytical techniques: their uptake, retention, and chemical forms , 2010, Analytical and bioanalytical chemistry.

[172]  Marianne Geiser,et al.  Deposition and biokinetics of inhaled nanoparticles , 2010, Particle and Fibre Toxicology.

[173]  Jeng-Jong Hwang,et al.  Therapeutic Efficacy Evaluation of 111In-Labeled PEGylated Liposomal Vinorelbine in Murine Colon Carcinoma with Multimodalities of Molecular Imaging , 2009, Journal of Nuclear Medicine.

[174]  W. Lu,et al.  DNA damage and oxidative stress in human liver cell L‐02 caused by surface water extracts during drinking water treatment in a waterworks in China , 2009, Environmental and molecular mutagenesis.

[175]  Jeffrey I Ellis,et al.  The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens. , 2009, Journal of the American Academy of Dermatology.

[176]  E. Sausville,et al.  Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery. , 2009, Molecular pharmaceutics.

[177]  Xiaoke Zhang,et al.  Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. , 2009, Biomaterials.

[178]  Vincent M. Rotello,et al.  Multimodal drug delivery using gold nanoparticles. , 2009, Nanoscale.

[179]  Mina Choi,et al.  The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. , 2009, Toxicology letters.

[180]  Brahim Lounis,et al.  Cathepsin L digestion of nanobioconjugates upon endocytosis. , 2009, ACS nano.

[181]  Iseult Lynch,et al.  Protein-nanoparticle interactions: What does the cell see? , 2009, Nature nanotechnology.

[182]  Günter Oberdörster,et al.  Nanoparticles and the brain: cause for concern?. , 2009, Journal of nanoscience and nanotechnology.

[183]  A. Bao,et al.  [(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model. , 2009, Nuclear medicine and biology.

[184]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[185]  John C Bischof,et al.  Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. , 2009, Nanomedicine.

[186]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[187]  H. McMahon,et al.  Mechanisms of endocytosis. , 2009, Annual review of biochemistry.

[188]  Håkan Wallin,et al.  Protracted elimination of gold nanoparticles from mouse liver. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[189]  Jeng-Jong Hwang,et al.  Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. , 2009, Anticancer research.

[190]  D. Jaffray,et al.  Intracellular uptake, transport, and processing of nanostructures in cancer cells. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[191]  Y. Hung,et al.  Assessment of the In Vivo Toxicity of Gold Nanoparticles , 2009, Nanoscale research letters.

[192]  Eun-Mi Kim,et al.  Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system. , 2009, International journal of pharmaceutics.

[193]  J. Borak Nanotoxicology: Characterization, Dosing, and Health Effects , 2009 .

[194]  W. Saltzman,et al.  The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. , 2009, Biomaterials.

[195]  R. Reis,et al.  Development of new chitosan/carrageenan nanoparticles for drug delivery applications. , 2009, Journal of biomedical materials research. Part A.

[196]  Eun-Jung Park,et al.  Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. , 2009, Toxicology letters.

[197]  Conroy Sun,et al.  Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. , 2008, Small.

[198]  A. Reiss,et al.  A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome , 2008, Journal of Neurodevelopmental Disorders.

[199]  Kemin Wang,et al.  In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. , 2008, Analytical chemistry.

[200]  P. Choyke,et al.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.

[201]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[202]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[203]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[204]  Christian Mühlfeld,et al.  Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. , 2008, Swiss medical weekly.

[205]  Igor L. Medintz,et al.  Potential clinical applications of quantum dots , 2008, International journal of nanomedicine.

[206]  Wei Yang,et al.  Inhaled nanoparticles--a current review. , 2008, International journal of pharmaceutics.

[207]  C. Unger,et al.  A phase IIa study of PEGylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-L-norleucine (DON) in patients with advanced refractory solid tumors , 2008 .

[208]  B. Zhivotovsky,et al.  Mitochondria in cancer cells: what is so special about them? , 2008, Trends in cell biology.

[209]  Tycho Heimbach,et al.  Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.

[210]  Kenneth A. Dawson,et al.  Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.

[211]  竜弘 石田,et al.  ポリエチレングリコール修飾リポソーム投与時に生ずる Accelerated Blood Clearance (ABC)現象 , 2008 .

[212]  K. Ritchie,et al.  Single molecule studies of molecular diffusion in cellular membranes: determining membrane structure. , 2007, Biopolymers.

[213]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[214]  Wolfgang A. Weber,et al.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[215]  Robert Langer,et al.  Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. , 2007, Nano letters.

[216]  G. Moseley,et al.  Targeted delivery to the nucleus. , 2007, Advanced drug delivery reviews.

[217]  J. Paul Luzio,et al.  Lysosomes: fusion and function , 2007, Nature Reviews Molecular Cell Biology.

[218]  P. Keegan,et al.  FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). , 2007, The oncologist.

[219]  Herbert J Meiselman,et al.  Antibody against poly(ethylene glycol) adversely affects PEG‐asparaginase therapy in acute lymphoblastic leukemia patients , 2007, Cancer.

[220]  Chih-Hsien Chang,et al.  Biodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-bMEDA-liposome in a C26 murine colon carcinoma solid tumor animal model. , 2007, Anticancer research.

[221]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[222]  A. Periclou,et al.  Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. , 2007, Blood.

[223]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[224]  Zheng-Rong Lu,et al.  Biodistribution and pharmacokinetics of colon-specific HPMA copolymer--9-aminocamptothecin conjugate in mice. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[225]  J. D. Payne,et al.  Application of INAA to the build-up and clearance of gold nanoshells in clinical studies in mice , 2007 .

[226]  S. Grinstein,et al.  LAMP proteins are required for fusion of lysosomes with phagosomes , 2007, The EMBO journal.

[227]  S. Randell,et al.  Cystic Fibrosis and Other Respiratory Diseases of Impaired Mucus Clearance , 2007, Toxicologic pathology.

[228]  Lang Tran,et al.  Safe handling of nanotechnology , 2006, Nature.

[229]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[230]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[231]  Maureen R. Gwinn,et al.  Nanoparticles: Health Effects—Pros and Cons , 2006, Environmental health perspectives.

[232]  J. Bonifacino,et al.  Retrograde transport from endosomes to the trans-Golgi network , 2006, Nature Reviews Molecular Cell Biology.

[233]  Jianjun Cheng,et al.  Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing mice , 2006, Cancer Chemotherapy and Pharmacology.

[234]  S. Schürch,et al.  Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. , 2006, Environmental science & technology.

[235]  Scott H Randell,et al.  Effective mucus clearance is essential for respiratory health. , 2006, American journal of respiratory cell and molecular biology.

[236]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[237]  J. Keelan,et al.  Active transport across the human placenta: impact on drug efficacy and toxicity , 2006, Expert opinion on drug metabolism & toxicology.

[238]  K. Wenner,et al.  Asparagine Concentration in Plasma After 2 500 IU/m² PEG-Asparaginase i.v. in Children With Acute Lymphoblastic Leukemia , 2005, Klinische Padiatrie.

[239]  Kai Sun,et al.  Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. , 2005, Nano letters.

[240]  Ron C. Hardman A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.

[241]  Jinhan Cho,et al.  Investigation of the Interactions between Ligand-Stabilized Gold Nanoparticles and Polyelectrolyte Multilayer Films , 2005 .

[242]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[243]  Wolfgang Kreyling,et al.  Ultrafine Particles Cross Cellular Membranes by Nonphagocytic Mechanisms in Lungs and in Cultured Cells , 2005, Environmental health perspectives.

[244]  F. Veronese,et al.  PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. , 2005, Bioconjugate chemistry.

[245]  K. Tryggvason,et al.  How does the kidney filter plasma? , 2005, Physiology.

[246]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[247]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[248]  A. Bjørnerud,et al.  Long‐term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent , 2004, Journal of magnetic resonance imaging : JMRI.

[249]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[250]  R H Guy,et al.  Skin penetration and distribution of polymeric nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[251]  A. Devitt,et al.  The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? , 2004, Immunology.

[252]  M. Basu,et al.  Macrophage specific drug delivery in experimental leishmaniasis. , 2004, Current molecular medicine.

[253]  K. Kairemo,et al.  Targeted liposomal drug delivery in cancer. , 2004, Current pharmaceutical design.

[254]  K. Tryggvason,et al.  The Scavenger Receptor MARCO Is Required for Lung Defense against Pneumococcal Pneumonia and Inhaled Particles , 2004, The Journal of experimental medicine.

[255]  I. Sondi,et al.  Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. , 2004, Journal of colloid and interface science.

[256]  Y. Yoshioka,et al.  The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. , 2004, Biomaterials.

[257]  Selcan Türker,et al.  Nasal route and drug delivery systems , 2004, Pharmacy World and Science.

[258]  Marco Peters,et al.  Scintigraphic measurement of tracheal mucus velocity in vivo , 2004, European Respiratory Journal.

[259]  J. Schellens,et al.  Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma , 2004, Cancer Chemotherapy and Pharmacology.

[260]  G. Molineux The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta). , 2004, Current pharmaceutical design.

[261]  T. Allen,et al.  Ligand-targeted liposomal anticancer drugs. , 2003, Progress in lipid research.

[262]  H. Stenmark,et al.  Protein sorting into multivesicular endosomes. , 2003, Current opinion in cell biology.

[263]  R. Duncan The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[264]  N. Heintz,et al.  To beat or not to beat: roles of cilia in development and disease. , 2003, Human molecular genetics.

[265]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[266]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[267]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[268]  Ken Jacobson,et al.  A Role for Lipid Shells in Targeting Proteins to Caveolae, Rafts, and Other Lipid Domains , 2002, Science.

[269]  J. Kamps,et al.  Massive and Selective Delivery of Lipid-Coated Cationic Lipoplexes of Oligonucleotides Targeted in Vivo to Hepatic Endothelial Cells , 2002, Pharmaceutical Research.

[270]  J. Klumperman,et al.  Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward lysosomes. , 2002, Molecular biology of the cell.

[271]  J. Neglia,et al.  A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. , 2002, Blood.

[272]  M. Knowles,et al.  Mucus clearance as a primary innate defense mechanism for mammalian airways. , 2002, The Journal of clinical investigation.

[273]  R. Beier,et al.  Drug Monitoring of PEG-Asparaginase Treatment in Childhood Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma , 2002, Leukemia & lymphoma.

[274]  I. Macara Transport into and out of the Nucleus , 2001, Microbiology and Molecular Biology Reviews.

[275]  F. Brodsky,et al.  Biological basket weaving: formation and function of clathrin-coated vesicles. , 2001, Annual review of cell and developmental biology.

[276]  G. Kroemer,et al.  Organelle-specific initiation of cell death pathways , 2001, Nature Cell Biology.

[277]  W. Deen,et al.  Structural determinants of glomerular permeability. , 2001, American journal of physiology. Renal physiology.

[278]  B. W. Barry,et al.  Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[279]  M. Gumbleton Caveolae as potential macromolecule trafficking compartments within alveolar epithelium. , 2001, Advanced drug delivery reviews.

[280]  B. Haraldsson,et al.  A gel-membrane model of glomerular charge and size selectivity in series. , 2001, American journal of physiology. Renal physiology.

[281]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[282]  Zhi-xin Xu,et al.  Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C. , 2001, Bioconjugate chemistry.

[283]  M. Edidin Membrane Cholesterol, Protein Phosphorylation, and Lipid Rafts , 2001, Science's STKE.

[284]  H. Harashima,et al.  Biodistribution of liposomes and C3 fragments associated with liposomes: evaluation of their relationship. , 2000, International journal of pharmaceutics.

[285]  V. Ganapathy,et al.  Placental transporters relevant to drug distribution across the maternal-fetal interface. , 2000, The Journal of pharmacology and experimental therapeutics.

[286]  G. Oberdörster,et al.  Determinants of the pathogenicity of man-made vitreous fibers (MMVF) , 2000, International archives of occupational and environmental health.

[287]  K. Syrigos,et al.  Biodistribution and pharmacokinetics of111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies , 2000, British Journal of Cancer.

[288]  A. Busnaina,et al.  The adhesion of dry particles in the nanometer to micrometer-size range , 2000 .

[289]  F. Maxfield,et al.  Characterization of Rapid Membrane Internalization and Recycling* , 2000, The Journal of Biological Chemistry.

[290]  R. Jain,et al.  Role of extracellular matrix assembly in interstitial transport in solid tumors. , 2000, Cancer research.

[291]  A. Bush,et al.  Primary ciliary dyskinesia (PCD) , 2000, Pediatric pulmonology.

[292]  C. M. Gupta,et al.  Tuftsin-bearing liposomes in treatment of macrophage-based infections. , 2000, Advanced drug delivery reviews.

[293]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[294]  M. Vert,et al.  Poly(ethylene glycol): Protein-repulsive or albumin-compatible? , 2000, Journal of biomaterials science. Polymer edition.

[295]  C H Lorenz,et al.  Characterization of t1 relaxation and blood‐myocardial contrast enhancement of NC100150 injection in cardiac MRI , 1999, Journal of magnetic resonance imaging : JMRI.

[296]  S. Pfeffer Motivating endosome motility , 1999, Nature Cell Biology.

[297]  Y. Quinn,et al.  New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. , 1999, Bioconjugate chemistry.

[298]  M. Hashida,et al.  Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[299]  T. Waldmann,et al.  The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points. , 1999, Cancer research.

[300]  Mandip Singh,et al.  Lipophilic drug derivatives in liposomes , 1998 .

[301]  David J Brayden,et al.  Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[302]  A. Salinaro,et al.  Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients , 1997, FEBS letters.

[303]  J. Patton,et al.  Mechanisms of macromolecule absorption by the lungs , 1996 .

[304]  P. Cullis,et al.  β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of "Non-self" Particles (*) , 1995, The Journal of Biological Chemistry.

[305]  S. Davis,et al.  Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics , 1995 .

[306]  Y. Aramaki,et al.  Identification of the serum factor required for liposome-primed activation of mouse peritoneal macrophages. Modified alpha 2-macroglobulin enhances Fc gamma receptor-mediated phagocytosis of opsonized sheep red blood cells. , 1995, Immunology.

[307]  F. Marincola,et al.  The use of polyethylene glycol‐modified interleukin‐2 (PEG‐IL‐2) in the treatment of patients with metastatic renal cell carcinoma and melanoma , 1995, Cancer.

[308]  H. Harashima,et al.  Kinetic modelling of liposome degradation in serum: Effect of size and concentration of liposomes in vitro , 1994, Biopharmaceutics & drug disposition.

[309]  G. Storm,et al.  Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. , 1993, Biochimica et biophysica acta.

[310]  B. Issell,et al.  Polyethylene glycol conjugated interleukin-2: Clinical and immunologic effects in patients with advanced renal cell carcinoma , 1993, Investigational New Drugs.

[311]  T. Okano,et al.  Biodistribution of Micelle-Forming Polymer–Drug Conjugates , 1993, Pharmaceutical Research.

[312]  K. Funato,et al.  Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. , 1992, Biochimica et biophysica acta.

[313]  M. Fukuda,et al.  Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. , 1991, The Journal of biological chemistry.

[314]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[315]  H. Maeda,et al.  SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. , 1991, Advanced drug delivery reviews.

[316]  H. Arai,et al.  Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. , 1990, The Journal of biological chemistry.

[317]  T. Allen,et al.  Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. , 1989, Biochimica et biophysica acta.

[318]  R. Havel,et al.  Hepatic metabolism of colloidal gold‐low‐density lipoprotein complexes in the rat: Evidence for bulk excretion of lysosomal contents into bile , 1989, Hepatology.

[319]  R K Jain,et al.  Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.

[320]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[321]  A. Helenius,et al.  Transport of macrophage Fc receptors and Fc receptor-bound ligands to lysosomes , 1986, The Journal of experimental medicine.

[322]  D. Falcone Fluorescent Opsonization Assay: Binding of Plasma Fibronectin to Fibrin‐Derivatized Fluorescent Particles Does Not Enhance Their Uptake by Macrophages , 1986, Journal of leukocyte biology.

[323]  J. Dijkstra,et al.  Uptake and Intracellular Processing of Targeted and Nontargeted Liposomes by Rat Kupffer Cells In Vivo and In Vitro a , 1985, Annals of the New York Academy of Sciences.

[324]  C. Verhoest,et al.  Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. , 1984, Cancer biochemistry biophysics.

[325]  G. Gregoriadis,et al.  Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. , 1982, Life sciences.

[326]  R. Juliano,et al.  Interactions of liposomes with the reticuloendothelial system. Effects of reticuloendothelial blockade on the clearance of large unilamellar vesicles. , 1981, Biochimica et biophysica acta.

[327]  J. Volanakis,et al.  Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. , 1981, Journal of immunology.

[328]  H. Wada,et al.  Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol. , 1981, The Journal of pharmacology and experimental therapeutics.

[329]  C. Alving,et al.  Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[330]  E R Weibel,et al.  The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. , 1978, Respiration physiology.

[331]  S. Singer,et al.  The Fluid Mosaic Model of the Structure of Cell Membranes , 1972, Science.

[332]  P. Rous,et al.  SELECTION WITH THE MAGNET AND CULTIVATION OF "RETICULOENDOTHELIAL" CELLS. , 1933, Science.

[333]  K. Fromm,et al.  Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cells. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[334]  B. Rothen‐Rutishauser,et al.  Plasmonic nanoparticles and their characterization in physiological fluids. , 2016, Colloids and surfaces. B, Biointerfaces.

[335]  Min Li,et al.  Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles , 2016, The AAPS Journal.

[336]  Maxime Henry,et al.  Nebulized gadolinium-based nanoparticles: a theranostic approach for lung tumor imaging and radiosensitization. , 2015, Small.

[337]  Hermann Nirschl,et al.  Upscaling of Bio-Nano-Processes , 2014 .

[338]  K. Ravichandran,et al.  Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. , 2013, Cold Spring Harbor perspectives in biology.

[339]  Marc Schneider,et al.  Interaction of inorganic nanoparticles with the skin barrier: current status and critical review. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[340]  Weiping Cai,et al.  Fabrication of self-standing silver nanoplate arrays by seed-decorated electrochemical route and their structure-induced properties , 2013 .

[341]  V. Venditto,et al.  Cancer nanomedicines: so many papers and so few drugs! , 2013, Advanced drug delivery reviews.

[342]  M. Vicent,et al.  Polymer therapeutics-prospects for 21st century: the end of the beginning. , 2013, Advanced drug delivery reviews.

[343]  K. Braeckmans,et al.  Intracellular partitioning of cell organelles and extraneous nanoparticles during mitosis. , 2012, Advanced drug delivery reviews.

[344]  J. Pluta,et al.  In vivo study on the biodistribution of silica particles in the bodies of rats. , 2012, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[345]  P. Couvreur,et al.  Prodrug-based intracellular delivery of anticancer agents. , 2011, Advanced drug delivery reviews.

[346]  W. Kreyling,et al.  Dosimetry of Inhaled Nanoparticles , 2010 .

[347]  Michelle Bradbury,et al.  Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. , 2009, Nano letters.

[348]  Y. Leung,et al.  Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. , 2007, Cancer research.

[349]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[350]  J. Kopeček,et al.  Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice. , 2001, European journal of cancer.

[351]  O. Boerman,et al.  In vivo applications of PEG liposomes: unexpected observations. , 2001, Critical reviews in therapeutic drug carrier systems.

[352]  L. Pilarski,et al.  Cellular Trafficking and Cytotoxicity of Anti-Cd19-Targeted Liposomal Doxorubicin in B Lymphoma Cells , 1999 .

[353]  A. Aderem,et al.  Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.

[354]  S. Schmid,et al.  Clathrin-coated vesicle formation and protein sorting: an integrated process. , 1997, Annual review of biochemistry.

[355]  H M Patel,et al.  Serum opsonins and liposomes: their interaction and opsonophagocytosis. , 1992, Critical reviews in therapeutic drug carrier systems.

[356]  R. Kelly,et al.  Constitutive and regulated secretion of proteins. , 1987, Annual review of cell biology.

[357]  J. Heyder,et al.  Deposition of particles in the human respiratory tract in the size range 0.005–15 μm , 1986 .

[358]  K. Unger,et al.  The use of porous and surface modified silicas as drug delivery and stabilizing agents , 1983 .

[359]  F F SAVERIO,et al.  [Cerebral circulation]. , 1954, Omnia therapeutica. Supplemento.